25 related articles for article (PubMed ID: 23517743)
1. Impact of recurrent copy number alterations and cancer gene mutations on the predictive accuracy of prognostic models in clear cell renal cell carcinoma.
Hakimi AA; Mano R; Ciriello G; Gonen M; Mikkilineni N; Sfakianos JP; Kim PH; Motzer RJ; Russo P; Reuter VE; Hsieh JJ; Ostrovnaya I
J Urol; 2014 Jul; 192(1):24-9. PubMed ID: 24518768
[TBL] [Abstract][Full Text] [Related]
2. D-loop Mutations in Renal Cell Carcinoma Improve Predictive Accuracy for Cancer-Related Death by Integrating with Mutations in the
Kim H; Komiyama T; Nitta M; Kawamura Y; Hasegawa M; Shoji S; Orihashi Y; Inomoto C; Kajiwara H; Nakamura N; Kobayashi H; Miyajima A
Genes (Basel); 2019 Dec; 10(12):. PubMed ID: 31810328
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil-to-lymphocyte ratio predicts prognosis of patients with hepatocellular carcinoma: a systematic review and meta-analysis.
Lin S; Hu S; Ran Y; Wu F
Transl Cancer Res; 2021 Apr; 10(4):1667-1678. PubMed ID: 35116492
[TBL] [Abstract][Full Text] [Related]
4. A Mitochondrial Dysfunction and Oxidative Stress Pathway-Based Prognostic Signature for Clear Cell Renal Cell Carcinoma.
Wu Y; Zhang X; Wei X; Feng H; Hu B; Deng Z; Liu B; Luan Y; Ruan Y; Liu X; Liu Z; Liu J; Wang T
Oxid Med Cell Longev; 2021; 2021():9939331. PubMed ID: 34868460
[TBL] [Abstract][Full Text] [Related]
5. An eleven metabolic gene signature-based prognostic model for clear cell renal cell carcinoma.
Wu Y; Wei X; Feng H; Hu B; Liu B; Luan Y; Ruan Y; Liu X; Liu Z; Wang S; Liu J; Wang T
Aging (Albany NY); 2020 Nov; 12(22):23165-23186. PubMed ID: 33221754
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and prognostic models for renal cell carcinoma: a literature review.
Klatte T; Rossi SH; Stewart GD
World J Urol; 2018 Dec; 36(12):1943-1952. PubMed ID: 29713755
[TBL] [Abstract][Full Text] [Related]
7. Can preoperative neutrophil lymphocyte ratio predict malignancy in patients undergoing partial nephrectomy because of renal mass?
Gorgel SN; Ozer K; Kose O; Dindar AS
Int Braz J Urol; 2018; 44(3):461-466. PubMed ID: 29211406
[TBL] [Abstract][Full Text] [Related]
8. Distribution of allelic and genotypic frequencies of IL1A, IL4, NFKB1 and PAR1 variants in Native American, African, European and Brazilian populations.
Amador MA; Cavalcante GC; Santos NP; Gusmão L; Guerreiro JF; Ribeiro-dos-Santos Â; Santos S
BMC Res Notes; 2016 Feb; 9():101. PubMed ID: 26879815
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of the neutrophil-lymphocyte ratio in renal cell carcinoma: a meta-analysis.
Hu K; Lou L; Ye J; Zhang S
BMJ Open; 2015 Apr; 5(4):e006404. PubMed ID: 25854964
[TBL] [Abstract][Full Text] [Related]
10. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
[TBL] [Abstract][Full Text] [Related]
11. A Meta-Analysis Evaluating Clinical Outcomes of Patients with Renal Cell Carcinoma Harboring Chromosome 9P Loss.
Di Nunno V; Mollica V; Brunelli M; Gatto L; Schiavina R; Fiorentino M; Santoni M; Montironi R; Caliò A; Eccher A; Milella M; Martignoni G; Brunocilla E; Massari F
Mol Diagn Ther; 2019 Oct; 23(5):569-577. PubMed ID: 31332726
[TBL] [Abstract][Full Text] [Related]
12. The protease activated receptor 1 gene variation IVSn -14 A>T is associated with distant metastasis and cancer specific survival in renal cell carcinoma.
de Martino M; Haitel A; Schatzl G; Klatte T
J Urol; 2013 Oct; 190(4):1392-7. PubMed ID: 23517743
[TBL] [Abstract][Full Text] [Related]
13. The CASP8 -652 6N insertion/deletion promoter polymorphism is associated with renal cell carcinoma risk and metastasis.
de Martino M; Haitel A; Schatzl G; Klingler HC; Klatte T
J Urol; 2013 Aug; 190(2):717-22. PubMed ID: 23313206
[TBL] [Abstract][Full Text] [Related]
14. Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas.
Kawai Y; Sakano S; Korenaga Y; Eguchi S; Naito K
Eur Urol; 2007 Oct; 52(4):1147-55. PubMed ID: 17287073
[TBL] [Abstract][Full Text] [Related]
15. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
